Skip to main content
. 2022 Sep;10(18):1026. doi: 10.21037/atm-22-3746

Figure 1.

Figure 1

The CT scan indicated limited disease progression following sunitinib treatment, with the liver (S7) lesion enlarged, and the other lesions stable on February 22, 2021. (A) The tumor in the hepatic S7. (B) The peritoneal lesion. (C) The tumor below the head of the pancreas. CT, computed tomography.